title: [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
authors.forename: A M
authors.initials: AM
authors.lastname: Lila
authors.forename: V I
authors.initials: VI
authors.lastname: Mazurov
authors.forename: A A
authors.initials: AA
authors.lastname: Novik
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D010266:Paraproteins / Q000032:analysis; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D012307:Risk Factors; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D010266:Paraproteins; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008558:Melphalan; D011241:Prednisone